You are here: Industry Insights > Biological E

News List

Biological E aims to produce 100 million doses/month of Corbevax from Feb 2022 ExpressPharma
December 29, 2021
Biological E plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022...
India authorises J&J’s Covid-19 vaccine for emergency use pharmaceutical-technology
August 09, 2021
India has approved Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for emergency use, expanding the total number of anti-SARS-CoV-2 vaccines authorised in the country to five.
Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate prnewswire
July 07, 2021
Dynavax Technologies Corporation today announced the execution of a commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant, for use in BE's subunit COVID-19 vaccine candidate, CORBEVAX™.
Biological E to produce Providence Therapeutics’ mRNA COVID-19 vaccine in India expresspharma
June 03, 2021
Biological E has entered into an agreement with Canada-based Providence Therapeutics Holdings, to manufacture the latter’s mRNA (messenger Ribonucleic acid) vaccine PTX-COVID19-B in India.
J&J COVID-19 vaccine may be imported by July expresspharma
April 25, 2021
India has said it would fast-track emergency approvals for COVID-19 vaccines authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson and Moderna shots.
Efforts to ramp up production of COVID-19 vaccines, easy availability underway: Renu Swarup expresspharma
April 23, 2021
The regulators have also permitted manufacturing at risk and stockpiling doses even before approval so that they can be rolled out into the immunisation programme without any time lag, she said.
Indian pharma companies say they can quickly rework vaccines to tackle COVID-19 variants expresspharma
February 24, 2021
India is the world’s biggest maker of vaccines, and its companies have promised to produce billions of doses of COVID-19 shots.
J&J to bring COVID-19 vaccine to India in partnership with Biological E expresspharma
February 10, 2021
Biological E has said it can produce 600 million doses for J&J and more than one billion doses a year of its own vaccine, developed with Baylor College of Medicine and Dynavax Technologies Corp.
InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization prnasia
January 19, 2021
InDevR, Inc. announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen quantification kit.
CEPI to help advance development and manufacture of COVID-19 vaccine from Biological E expresspharma
December 30, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) and Biological E, India announced a collaboration to advance the development and manufacture of Biological E’s COVID-19 subunit vaccine candidate.

Previous page 1 2 Next page